Research Hub

Compare peptide evidence scores and risk levels across all verified compounds.

Published
69
High Evidence
37
Low Risk
27

Evidence Score Ranking

← Swipe to view all
SemaglutideLiraglutideTirzepatideSemaglutide oralRetatrutideTesofensineSurvodutideGlucagonExenatideGhrelinTesamorelinLarazotide (AT-1001)Lutathera (Lu-177 DOTATATE)GLP-1 Combination (Semaglutide + Cagrilintide)Melphalan FlufenamideACTHCJC-1295Glucagon-like Peptide-2 (GLP-2)Oral Peptide Delivery (SNAC)CagrilintideSermorelinThymosin Beta-4 / TB-500Substance PGHK-CuPeptide-Drug Conjugate (PDC)Stellate Ganglion Block (SGB)Neuropeptide Y (NPY)PT-141 / BremelanotideBPC-157LY3819253Combinatorial Peptide ProtocolsMK-677Cholecystokinin (CCK)ApelinPeptide YY (PYY)OxytocinLL-37Intranasal Peptide DeliveryPeptide Library ScreeningIpamorelinGonadorelinKisspeptinAngiotensin-(1-7)TB-500Delta Sleep-Inducing Peptide (DSIP)SemaxZiltivekimabC-peptideMotilinHexarelinGHRP-2Vasoactive Intestinal Peptide (VIP)GHRP-6AOD-9604SS-31 (Elamipretide)AI-Designed PeptidesUroguanylinSecretinPeptide Biomarker TestingDeltorphinTransdermal Peptide PatchNeurotensinEpitalonMOTS-cPersonalized Peptide TherapyPinealonMelanotan-IISelankEpithalon0255075100

Risk vs Evidence Profile

92888585858280807575757272707070706868686565656560605855525039Evidence ScoreLOWMODHIGH
LOW
MODERATE
HIGH
UNKNOWN

Have additional data on this topic?

Spotted a study, dataset, or official source we missed? Submit a link and our editorial team will review it and, if it checks out, fold it into this article.